AML-392 Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm in Pediatric Patients With Tagraxofusp, a CD123-Targeted Therapy

Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya, Anthony S. Stein, Soheil Meshinchi, Craig Mullen, Emanuele Angelucci, Luciana Vinti, Tariq I. Mughal, Anna Pawlowska

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S244-S245
JournalClinical Lymphoma, Myeloma and Leukemia
Volume22
DOIs
StatePublished - Oct 2022

ASJC Scopus Subject Areas

  • Hematology
  • Oncology
  • Cancer Research

Keywords

  • AML
  • BPDCN
  • CD123
  • TAG
  • pediatric
  • plasmacytoid dendritic cell
  • tagraxofusp
  • targeted therapy

Cite this